Citation: Circulation. 137(24):2635-2650, 2018 Jun 12..Journal: Circulation.Published: 2018ISSN: 0009-7322.Full author list: Garcia-Garcia HM; McFadden EP; Farb A; Mehran R; Stone GW; Spertus J; Onuma Y; Morel MA; van Es GA; Zuckerman B; Fearon WF; Taggart D; Kappetein AP; Krucoff MW; Vranckx P; Windecker S; Cutlip D; Serruys PW; Academic Research Consortium.UI/PMID: 29891620.Subject(s): IN PROCESS -- NOT YET INDEXEDInstitution(s): MedStar Heart & Vascular InstituteActivity type: Journal Article.Medline article type(s): Journal Article | ReviewOnline resources: Click here to access onlineDigital Object Identifier: https://dx.doi.org/10.1161/CIRCULATIONAHA.117.029289 (Click here)Abbreviated citation: Circulation. 137(24):2635-2650, 2018 Jun 12.Local Holdings: Available online from MWHC library: 1950 - present, Available in print through MWHC library: 1999 - 2006.Abstract: The Academic Research Consortium (ARC)-2 initiative revisited the clinical and angiographic end point definitions in coronary device trials, proposed in 2007, to make them more suitable for use in clinical trials that include increasingly complex lesion and patient populations and incorporate novel devices such as bioresorbable vascular scaffolds. In addition, recommendations for the incorporation of patient-related outcomes in clinical trials are proposed. Academic Research Consortium-2 is a collaborative effort between academic research organizations in the United States and Europe, device manufacturers, and European, US, and Asian regulatory bodies. Several in-person meetings were held to discuss the changes that have occurred in the device landscape and in clinical trials and regulatory pathways in the last decade. The consensus-based end point definitions in this document are endorsed by the stakeholders of this document and strongly advocated for clinical trial purposes. This Academic Research Consortium-2 document provides further standardization of end point definitions for coronary device trials, incorporating advances in technology and knowledge. Their use will aid interpretation of trial outcomes and comparison among studies, thus facilitating the evaluation of the safety and effectiveness of these devices.Abstract: Copyright (c) 2018 American Heart Association, Inc., and European Society of Cardiology.